Home
>
National Drug Code (NDC)
>
Prochlorperazine Edisylate
Prochlorperazine Edisylate - 0641-0491-25 - (Prochlorperazine Edisylate)
Drug Information of Prochlorperazine Edisylate
| Product NDC: | 0641-0491 |
| Proprietary Name: | Prochlorperazine Edisylate |
| Non Proprietary Name: | Prochlorperazine Edisylate |
| Active Ingredient(s): | 5 mg/mL & nbsp; Prochlorperazine Edisylate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Prochlorperazine Edisylate
| Product NDC: | 0641-0491 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA089903 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110114 |
Package Information of Prochlorperazine Edisylate
| Package NDC: | 0641-0491-25 |
| Package Description: | 25 VIAL in 1 PACKAGE (0641-0491-25) > 2 mL in 1 VIAL (0641-0491-21) |
NDC Information of Prochlorperazine Edisylate
| NDC Code | 0641-0491-25 |
| Proprietary Name | Prochlorperazine Edisylate |
| Package Description | 25 VIAL in 1 PACKAGE (0641-0491-25) > 2 mL in 1 VIAL (0641-0491-21) |
| Product NDC | 0641-0491 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Prochlorperazine Edisylate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20110114 |
| Marketing Category Name | ANDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | PROCHLORPERAZINE EDISYLATE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Phenothiazine [EPC],Phenothiazines [Chemical/Ingredient] |
